To investigate the mechanism of radioresistance of solid tumor cells, we created two expression vectors encoding Survivin mutants, T34A and D53A. When T34A and D53A were overexpressed in NIH3T3, A549 and HeLa cells, radiation-induced apoptosis was significantly enhanced. Furthermore, we examined the binding capability of Survivin with Smac/DIABLO in the cells that overexpressed these mutants. Coimmunoprecipitation analysis revealed that mutant form of Survivin, D53A and T34A could bind to Smac/DIABLO, but with much less affinity compared to the authentic form. These results suggest that radiation-induced apoptosis of tumor cells is increased by inhibition of the interaction between Survivin and Smac/DIABLO through overexpression of T34A and D53A.
Introduction
Ionizing radiation is a useful tool for cancer therapy. In solid tumor cells derived from adenocarcinoma, squamous cell carcinoma or melanoma, it is generally considered that radiation-induced cell death mainly occurs through reproductive cell death but not apoptotic cell death. However, in hematopoietic cell lines, malignant lymphoma and leukemia cells [1] [2] [3] , etc., apoptotic cell death is prone to be induced by genotoxic agents, including ionizing radiation. In the treatment combined with some antitumor drugs, radiation-induced cell death is sometimes enhanced through an increase of apoptosis even in radioresistant solid tumor cell lines [4] [5] [6] . In fact, we have reported that a novel anticancer drug, 1-(3-C-ethynyl-β-D-ribo-pentofutanosyl)cytosine (ECyd), enhances radiation-induced apoptosis in human gastric adenocarcinoma MKN45 (p53 wild type), MKN28 (p53 mutation) and murine rectum adenocarcinoma Colon26 (p53 status unknown) cells. The decrease in the radiation-induced expression of Survivin, Bcl-2, cyclin B1 and Wee1 was partly responsible for the enhancement of radiation-induced apoptosis by ECyd regardless of p53 status and cell type in vitro [7] and in vivo [8] . Furthermore, in MKN45 and MKN28 cells, purvalanol A, a cyclin-dependent kinase inhibitor, also enhances radiation-induced cell killing through an increase of apoptosis by downregulation of inhibitor of apoptosis family (IAP) family members (Survivin and XIAP), Bcl-2 family members (Bcl-X L and Bcl-2), cyclin B1 and Wee1 [9] . Since it is generally considered that ionizing radiation promotes apoptotic signaling such as cytochrome c release from mitochondria, followed by activation of caspase-9, -3 or the caspase-activated deoxyribonuclease (DNase)(CAD) pathway [10, 11] , the constitutive or inducible anti-apoptotic proteins seem to inhibit this apoptotic signaling in the radioresistance of solid tumor cells. 4 Survivin is a member of the inhibitor of apoptosis protein (IAP) family protein [12] , which is intensively expressed in the G 2 /M phase and potentially involved in both inhibition of apoptosis and control of cell division [13] [14] [15] [16] . Its expression is prominently upregulated in most human cancer cells, but is undetectable or very low in normal tissues [17, 18] . The high expression of Survivin in cancer cells is a marker of negative prognostic significance and a cause of tumor resistance to therapies [19] [20] [21] [22] . The phosphorylation at threonine 34 of Survivin by Cdc2 is accepted to be essential for the anti-apoptotic activity of Survivin [23] ; however, the anti-apoptotic mechanisms of Survivin have remained controversial. Early studies suggested that the Survivin directly bound to caspase-3 and suppressed apoptosis [24, 25] . However, others failed to demonstrate direct effects on this protease [26] [27] [28] . As another possible mechanism, Song et al. [29] recently showed that Survivin bound to Smac/DIABLO, which is known as a proapoptotic protein that binds to IAPs such as XIAP, and prevents apoptosis by suppressing caspase-9 and -3. The replacement to alanine at aspartic acid 53 (D53A) of Survivin has been demonstrated to fail to associate with Smac/DIABLO and the disruption of this binding activity enhances TRAIL-, doxorubicin-and RIP3-induced apoptosis in HeLa cells [30] . However, the relationship between the phosphorylation of Survivin and its binding activity with Smac/DIABLO is still unclear.
In the present study, we examined whether ionizing radiation promoted cytochrome c release from mitochondria in A549 cells and Survivin was involved in inhibition of apoptotic signaling downstream of mitochondria. For this purpose, two expression vectors encoding Survivin mutants, T34A (phosphorylation-defect mutant) and D53A (defective in binding activity with Smac/DIABLO) were created.
Furthermore, binding activity of Survivin with Smac/DIABLO in the cells 5 overexpressing these mutants was also studied.
Materials and methods

Reagents
Carbobenzoxy-Val-Ala-Asp-fluoromethane (Z-VAD-fmk),
acetyl-Leu-Glu-His-Asp-aldehyde (Ac-LEHD-CHO),
acetyl-Asp-Glu-Val-Asp-aldehyde (Ac-DEVD-CHO) and acetyl-Ile-Glu-His-Asp-aldehyde (Ac-IETD-CHO) were from Peptide Institute (Osaka, Japan). Propidium iodide (PI) and nocodazole were from Sigma Chemical Company (St.
Louis, MO). 32 Pi (orthophosphoric acid) was from MP Biomedicals, Inc. (Irvine, CA).
Protein G-Sepharose was from Amersham-Pharmacia Biotech (Buckinghamshire, UK).
The following antibodies were used for western blotting and immunoprecipitation:
anti-Survivin and anti-actin (Santa Cruz Biotechnology, Santa Cruz, CA),
anti-cytochrome c (BD PharMingen, Erebodegem, Belgium), anti-Smac/DIABLO (Calbiochem) and anti-cleaved caspase-3 (Cell Signaling Technology, Beverly, MA).
The chemiluminescence detection kit, Western Lighting TM Chemiluminescence Reagent Plus, was from Perkin Elmer (Boston, MA).
Cell culture
Mouse fibroblast cell line NIH3T3, embryonic kidney cell line 293A and human cervical carcinoma cell line HeLa were grown in DMEM medium containing 10% fetal calf serum at 37°C in 5% CO 2 . Human lung carcinoma A549 cells were maintained in RPMI 1640 medium containing 10% fetal calf serum at 37°C in 5% CO 2 . 
PCR-mediated mutagenesis
The cDNA of Survivin was amplified by RT-PCR from total RNA of cell line HeLa and cloned into pCR2.1-TOPO (Invitrogen, Carlsbad, CA). To obtain the Survivin mutants, Survivin-T34A (T34A), -D53A (D53A), -T34E (T34E) and -T34D (T34D), we employed PCR-mediated mutagenesis. Mutations were further verified using the CEQ8000 DNA Analysis System (Beckman Coulter, Fullerton, CA).
Plasmid construction and transfection
The amplified cDNAs of WT and its mutants were subsequently cloned into 
Adenoviral construction and transduction
The cDNAs of WT and its mutants were inserted into pAd/CMV/V5-DEST (Invitrogen). Replicant-defective adenoviral vectors pAd-LacZ, pAd-WT, pAd-T34A
and pAd-D53A were generated using the Virapower Adenoviral Expression System (Invitrogen). Viral titers were determined using an Adeno-X TM Rapid Titer kit (Clontech). Subconfluent cultures of the tumor cell lines were incubated with pAd vectors at MOI 50 and the virus was allowed to adhere for 1 h at 37°C. Then medium was added and the incubation was continued under the same conditions for an additional 7 24 h. For immunocytochemistry, the cells were fixed with 4% paraformaldehyde and analyzed for Survivin expression.
Treatment with X irradiation
At 24 h after transfection or transduction, the cells were irradiated with an X ray generator with a 1.0-mm aluminum filter at 200 kVp and 10 mA, (Shimazu HF-350, Kyoto) at a dose of 3.9 Gy/min, which was determined using Fricke's chemical dosimeter. Then they were incubated for another 48 h at 37°C. Addition of 20 μM caspase inhibitors, Z-VAD-fmk, Ac-LEHD-CHO, Ac-DEVD-CHO and Ac-IETD-CHO, was carried out at the same time as treatment with irradiation.
SDS-PAGE and Western blotting
The cells were collected 48 h after treatment with irradiation. The pellet was 
Assays of the release of cytochrome c from mitochondria
The cytosol of cells was prepared by a modification of the method of Bossy-Wetzel et al. [31] . Briefly, the cell pellet was resuspended in 300 μl of extraction buffer, containing 250 mM sucrose, 20 mM HEPES-KOH (pH 7.4), 10 mM KCl, 1.5 mM MgCl 2 , 1 mM EGTA, 1 mM dithiothreitol (DTT) and 1 mM PMSF. After 1 h incubation on ice, cells were disrupted with a homogenizer and centrifuged at 1,000 g for 10 min at 4°C to remove nuclei and unbroken cells. The supernatant was further centrifuged at 26,000 g for 30 min at 4°C to separate mitochondria. The cytochrome c in the cytosol was detected using SDS-PAGE and western blotting as described above.
Coimmunoprecipitation
Cells were lysed in a Triton X-100-based lysis buffer (1% Triton X-100, 10%
glycerol, 150 mM NaCl, 20 mM Tris, pH 7.5, 2 mM EDTA, 1 mM PMSF, 10 μg/ml leupeptin, 10 μg/ml aprotinin and 10 μg/ml pepstatin) overnight, and the nuclear and cellular debris was cleared by centrifugation. Then the lysed cytosol was mixed with a Smac/DIABLO monoclonal antibody bound to Protein G-Sepharose. After overnight incubation at 4°C, the immunoprecipitates were washed two times in lysis buffer, and proteins were recovered by boiling beads in SDS sample buffer and analyzed by western blotting.
Detection of phosphorylated Survivin in A549 cells
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A549 cells were incubated with phosphate-free medium containing 0.2 mCi/ml 32 Pi and 5% dialyzed FBS for 1 h, and then 100 ng/ml nocodazole was added to the medium. After incubation for 6 h, proteins in the cell lysates were immunoprecipitated by anti-Survivin antibody as described above and were separated by SDS-PAGE.
Phosphorylated Survivin was visualized by autoradiography using the imaging analyzer (FUJIX BAS2500, Fuji photo Film, Tokyo, Japan). 
Detection of apoptotic cells by
Results
Radiation induces cytochrome c release from mitochondria and overexpression of
Smac/DIABLO but not apoptosis 10 We first examined whether ionizing radiation induced apoptotic cell death.
When A549 cells were exposed to 10 Gy of X rays and incubated for 12, 24, 36 and 48 h, the cells exhibited cell cycle arrest in the G 2 /M phase (Fig. 1A) and enlargement of nuclei (Fig. 1B) , but no increase of cells in sub-G 1 fraction or morphological changes such as nuclear condensation and fragmentation were observed. Moreover, X irradiation of A549 cells did not induce activation of caspase-3 in any incubation times as shown in Fig. 1C , though active fragments were easily observed in human leukemia MOLT-4 cells exposed to same dose of X rays. On the other hand, cytochrome c was released from mitochondria to cytosol in A549 cells (Fig. 1D ) and the expression of the proapoptotic protein Smac/DIABLO was also increased after irradiation (Fig. 1E) . It was suggested that the apoptotic signaling pathway was promoted until the mitochondrial level after irradiation, although activation of this signaling was not sufficient to achieve apoptotic cell death at the time examined.
Overexpression of Survivin mutants enhances radiation-induced apoptosis
To investigate whether constitutive Survivin in tumor cells was involved in antiapoptotic properties against Smac/DIABLO-related apoptotic signaling, which was promoted by ionizing radiation as mentioned above, we next constructed six GFP-fused plasmids:
Survivin-D53A/GFP (D53A), Survivin-T34E/GFP (T34E) and Survivin-T34D/GFP (T34D). We then transfected them to evaluate their ability to induce apoptosis in mouse fibroblast NIH3T3 cells prior to experiments in tumor cells. GFP-expressing cells observed by phase-contrast and fluorescence microscopy are shown in Fig. 2A .
Transfection of NIH3T3 cells with various GFP fused-vectors resulted in equally gained
11 intense GFP-labeling in about 70% of cells at 24 h (Fig. 2B) . The overexpression of proteins was also confirmed by western blot analysis (Fig. 2C) . In this SDS-PAGE pattern, the position of D53A in the gel was slightly shifted below and those of T34E
and T34D were shifted above in comparison with those of WT and T34A. These differences in the mobility of Survivin mutants were explained by loss and addition of negative charge by mutagenesis, since phosphorylation and dephosphorylation of Cdc2
[32], Wee1 [33] , Rb [34] and Sld1 [35] were reported to induce deceleration and acceleration in the migration in the gel, respectively. Next, we investigated the effects of (Fig. 3B) .
Survivin-T34A and -D53A enhance radiation-induced apoptosis in a caspase-dependent manner
Furthermore, to examine whether enhancement of apoptosis in X-irradiated NIH3T3 cells overexpressed with T34A and D53A was associated with caspase-3, immunoblotting for active fragments p17 of caspase-3 was performed. Fig. 3C showed that X irradiation induced active fragments of caspase-3 in the cells overexpressed with T34A and D53A but not GFP, WT, T34E and T34D. Next, we tested the effects of caspase inhibitors on the enhancement of radiation-induced apoptosis by overexpression with Survivin mutants in NIH3T3 cells (Fig. 3D) . The broad spectrum caspase inhibitor Z-VAD-fmk, caspase-3 inhibitor Ac-DEVD-CHO, caspase-8 inhibitor Ac-LEHD-CHO or caspase-9 inhibitor Ac-IETD-CHO, was added to culture at the same time as X irradiation. Addition of the broad-spectrum caspase, caspase-9 and caspase-3 inhibitors, but not the caspase-8 inhibitor, to the medium suppressed the enhancement of radiation-induced apoptosis (Fig. 3D ) in cells that overexpressed T34A or D53A.
Adenovirus-mediated overexpression of Survivin mutants enhances radiation-induced apoptosis in tumor cells
To achieve high-level and relatively long-term expression in tumor cells, we constructed replication-deficient adenoviral vectors encoding Survivin mutants. We used pAd-LacZ expressing β-galactosidase as a toxicity control for the virus.
Transduction with the adenoviral vector pAd-WT, pAd-T34A or pAd-D53A, resulted in the strong expression of Survivin in human lung carcinoma A549 and cervical carcinoma HeLa cells as proved by western blots (Fig. 4A) . Furthermore, immunocytochemistry revealed positive signals in almost all cells of both tumor lines (Fig. 4B ).
To clarify whether radiation-induced apoptosis was enhanced by Survivin mutants in tumor cell lines, the apoptotic induction in tumor cells with (Fig. 5C ).
Phosphorylation of Survivin is required for its interaction with Smac/DIABLO
At first, we carried out to examine phosphorylation status of Survivin-WT, -T34A and -D53A in the cells treated with nocodazole by using in vivo 
Discussion
It has been reported that the Survivin mutant T34A, which is unable to be phosphorylated by Cdc2 at T34, competes with endogenous Survivin for access to kinases and thereby prevents the phosphorylation of wild-type Survivin [23] . When
Survivin-T34A and -D53A were overexpressed in NIH3T3, A549 and HeLa cells, radiation-induced apoptosis was significantly enhanced (Figs. 3 and 5 ). In comparison with the effects of various vectors on the enhancement of radiation-induced apoptosis in the cells, the enhancement of apoptosis induced by the overexpression of these mutants in HeLa cells (p53 null) was similar to that of A549 cells (p53 wild type), indicating that the enhancement by Survivin mutants occurred independently of p53 status (Fig. 5) . The enhancement by Survivin-T34A as well as -D53A was suppressed by caspase-9 and caspase-3 inhibitors but not a caspase-8 inhibitor (Figs. 3C and D) . It is well-known that caspase-9 is regulated by Apaf-1 and that cytochrome c released from mitochondria and caspase-8 is activated through formation of the death-inducing signaling complex (DISC) after the activation of death receptors (Fas and DR5, etc.). Though ionizing radiation was reported to activate not only the mitochondrial pathway but also the death receptor pathway without ligands in human leukemia MOLT-4 cells [3, 36] , the present results suggested that endogenous Survivin suppressed the caspase-3-dependent cell death via the mitochondrial pathway but not the death receptor pathway in NIH3T3, A549 and HeLa cells. In fact, the apoptotic signaling pathway was shown to be activated followed by mitochondrial downstream signaling activation such as cytochrome c release and expression of Smac/DIABLO after irradiation ( Fig. 1D and E) .
However, how Survivin-T34A accelerates caspase-3 dependent apoptosis has been unknown, because of the lack of experimental evidence that the recombinant Survivin-T34A directly associated with caspase-3 and/or Smac/DIABLO through the BIR domain.
As shown in Fig. 6A and B, we demonstrated that Survivin-T34A could not also bind to Smac/DIABLO similarly to Survivin-D53A and the clear phosphorylation of Survivin-WT and -D53A but not -T34A was detected, indicating that phosphorylation at T34 was associated with binding activity to Smac/DIABLO. Since functional Survivin has been demonstrated to be a homodimer of the wild type [14, 30] , if dimers containing Survivin-D53A fail to interact with Smac/DIABLO, the overexpression of this dominant-negative mutant may enhance the activation of caspases induced by 16 apoptotic stimuli. Since phosphorylation at T34 is essential for the anti-apoptotic function of Survivin [23] , phosphorylated Survivin at T34 may be necessary to bind with Smac/DIABLO in order to suppress apoptosis. Our results showed when the binding activity of Survivin with Smac/DIABLO was abrogated by Survivin mutants T34A and D53A, the formation of a Smac/DIABLO-IAPs complex was induced and then the processing of caspase-3 was facilitated by loss of the antiapoptotic properties of IAPs (Fig. 6C) . This is the first report to demonstrate the relationship between a phosphorylation-defective mutant of Survivin, T34A, and Smac/DIABLO.
To explore the role of the phosphorylation at T34 in the antiapoptotic activity of Survivin, we prepared phosphomimic mutants, i.e., T34E and T34D. A previous report showed that the activation of NADPH oxidase was regulated by phosphorylation at S303/S304 of p47 phox , an NADPH oxidase subunit, and this enzyme activation occurred in p47-deficient B-cells transfected with S303E/S304E but not S303D/S304D p47 phox mutants [37] . This report suggested that the introduction of a negative charge to a protein was not always involved in the protein function after phosphorylation and that the structural change due to phosphorylation was important in the case of NADPH oxidase. Contrast to this previous data, our results showed that not only T34E but also T34D did not enhance apoptosis (Fig. 3) , though the overexpression of T34A was shown to enhance radiation-induced apoptosis in NIH3T3 cells. These results suggest that the negative charge after Cdc2-dependent phosphorylation, but not the structural change in the amino acid residue, is necessary for the antiapoptotic functions of h. Fluorescence microscopic observation was performed using a protocol similar to that described as above. Data are expressed as means ± SE for three experiments. *p < 0.05, ** p<0.01 vs. X rays by Student's t-test. 
